Microbial natural products are among the main sources of compounds used in the medical biotechnology field for the purpose of drug development. However, as antibiotic resistance in pathogenic microorganisms is known to be increasing dramatically, there exists a need to develop new antibiotics. Actinomycetia have proven to be a good source of biologically active compounds, although the rediscovery of previously known compounds significantly slows down the introduction of new antibiotics. As a consequence, increasing attention is being paid to the isolation of actinomycete strains from previously unexplored sources, which can significantly increase the likelihood of discovering new biologically active compounds. This study investigated the diversity and bioactive potential of 372 actinomycete strains isolated from the rhizosphere soil of Juniperus excelsa M. Bieb. The examined actinomycete strains belonged to 11 genera, namely, Actinoplanes, Actinorectispora, Amycolatopsis, Kribbella, Micrococcus, Micromonospora, Nocardia, Promicromonospora, Rhodococcus, Saccharopolyspora and Streptomyces. The bioactive potential of each isolated actinomycete strain was determined on the basis of its ability to produce antimicrobial metabolites against Gram-positive and Gram-negative bacteria and yeast. Some 159 strains (42.74%) exhibited antimicrobial activity against at least one of the tested microbial strains. The dereplication analysis of the extract of the Streptomyces sp. Je 1-651 strain, which exhibited strong antimicrobial activity, led to the annotation of spiramycins and stambomycins. Moreover, the phylogenetic analysis based on the 16S rRNA gene sequence of the Je 1-651 strain revealed it to be close to the S. ambofaciens.

Department of Genetics and Biotechnology Ivan Franko National University of Lviv Lviv 79005 Ukraine

Department of Pharmaceutical Biotechnology Saarland University Saarbruecken 66123 Germany

Helmholtz Institute for Pharmaceutical Research Saarland Saarbruecken 66123 Germany

Microbial Culture Collection of Antibiotic Producers Ivan Franko National University of Lviv Lviv 79005 Ukraine

000      

00000naa a2200000 a 4500

001      

bmc23012426

003      

CZ-PrNML

005      

20230804101002.0

007      

ta

008      

230804s2023 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1007/s12223-023-01047-x $2 doi

035    __

$a (PubMed)36947395

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Tistechok, Stepan $u Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, 79005, Ukraine $1 https://orcid.org/000000032116746X

245    10

$a Diversity and bioactive potential of Actinomycetia from the rhizosphere soil of Juniperus excelsa / $c S. Tistechok, I. Roman, V. Fedorenko, A. Luzhetskyy, O. Gromyko

520    9_

$a Microbial natural products are among the main sources of compounds used in the medical biotechnology field for the purpose of drug development. However, as antibiotic resistance in pathogenic microorganisms is known to be increasing dramatically, there exists a need to develop new antibiotics. Actinomycetia have proven to be a good source of biologically active compounds, although the rediscovery of previously known compounds significantly slows down the introduction of new antibiotics. As a consequence, increasing attention is being paid to the isolation of actinomycete strains from previously unexplored sources, which can significantly increase the likelihood of discovering new biologically active compounds. This study investigated the diversity and bioactive potential of 372 actinomycete strains isolated from the rhizosphere soil of Juniperus excelsa M. Bieb. The examined actinomycete strains belonged to 11 genera, namely, Actinoplanes, Actinorectispora, Amycolatopsis, Kribbella, Micrococcus, Micromonospora, Nocardia, Promicromonospora, Rhodococcus, Saccharopolyspora and Streptomyces. The bioactive potential of each isolated actinomycete strain was determined on the basis of its ability to produce antimicrobial metabolites against Gram-positive and Gram-negative bacteria and yeast. Some 159 strains (42.74%) exhibited antimicrobial activity against at least one of the tested microbial strains. The dereplication analysis of the extract of the Streptomyces sp. Je 1-651 strain, which exhibited strong antimicrobial activity, led to the annotation of spiramycins and stambomycins. Moreover, the phylogenetic analysis based on the 16S rRNA gene sequence of the Je 1-651 strain revealed it to be close to the S. ambofaciens.

650    _2

$a antibakteriální látky $x farmakologie $x metabolismus $7 D000900

650    12

$a jalovec (rod) $x genetika $7 D018653

650    _2

$a rhizosféra $7 D058441

650    _2

$a fylogeneze $7 D010802

650    _2

$a RNA ribozomální 16S $x genetika $7 D012336

650    _2

$a půda $7 D012987

650    _2

$a gramnegativní bakterie $x genetika $7 D006090

650    _2

$a grampozitivní bakterie $7 D006094

650    12

$a antiinfekční látky $7 D000890

650    12

$a Actinobacteria $7 D039903

650    12

$a Actinomycetales $x genetika $7 D000192

650    12

$a Streptomyces $x genetika $7 D013302

650    _2

$a půdní mikrobiologie $7 D012988

655    _2

$a časopisecké články $7 D016428

700    1_

$a Roman, Ivan $u Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, 79005, Ukraine $1 https://orcid.org/000000034449739X

700    1_

$a Fedorenko, Victor $u Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, 79005, Ukraine $1 https://orcid.org/0000000276721897

700    1_

$a Luzhetskyy, Andriy $u Department of Pharmaceutical Biotechnology, Saarland University, Saarbruecken, 66123, Germany $u Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbruecken, 66123, Germany $1 https://orcid.org/0000000164970047

700    1_

$a Gromyko, Oleksandr $u Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, 79005, Ukraine. oleksandr.gromyko@lnu.edu.ua $u Microbial Culture Collection of Antibiotic Producers, Ivan Franko National University of Lviv, Lviv, 79005, Ukraine. oleksandr.gromyko@lnu.edu.ua $1 https://orcid.org/0000000281070128

773    0_

$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 68, č. 4 (2023), s. 645-653

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36947395 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230804 $b ABA008

991    __

$a 20230804100955 $b ABA008

999    __

$a ok $b bmc $g 1965346 $s 1198695

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 68 $c 4 $d 645-653 $e 20230322 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005

LZP    __

$a Pubmed-20230804